Orchestrated regulation of nogo receptors, lotus, AMPA receptors and BDNF in an ECT model suggests opening and closure of a window of synaptic plasticity

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Nordgren, Max ^a   Karlsson, Tobias ^a   Svensson, Maria ^b   Koczy, Josefin ^a   Josephson, Anna ^a   Olson, Lars ^a   Tingström, Anders ^b   Brené, Stefan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DENTATE GYRUS; DOWN-REGULATION; ELECTROCONVULSIVE THERAPY; GPI-LINKED PROTEINS; MALE; MYELIN PROTEINS; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, CELL SURFACE; SYNAPSES; TIME FACTORS;

EID: 84893676439     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078778     Document Type: Article

References (64)

1. Pagnin D, de Queiroz V, Pini S, Cassano GB (2004) Efficacy of ECT in depression: a meta-analytic review. J ECT 20: 13-20. (Pubitemid 38488810)
2. Angelucci F, Brenè S, Mathé AA (2005) BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry 10: 345-352. doi:10.1038/sj.mp.4001637
3. Merkl A, Heuser I, Bajbouj M (2009) Antidepressant electroconvulsive therapy: mechanism of action, recent advances and limitations. Exp Neurol 219: 20-26. doi:10.1016/j.expneurol.2009.04.027
4. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, et al. (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109: 143-148. (Pubitemid 34258493)
5. Angelucci F, Aloe L, Jiménez-Vasquez P, Mathé AA (2002) Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain. J ECT 18: 138-143. (Pubitemid 35192427)
6. Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15: 7539-7547.
7. Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59: 1116-1127. doi:10.1016/j.biopsych.2006.02. 013
8. Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, et al. (2000) Increased neurogenesis in a model of electroconvulsive therapy. Biological Psychiatry 47: 1043-1049. doi:10.1016/S0006-3223(00)00228-6 (Pubitemid 30336212)
9. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20: 9104-9110. (Pubitemid 32042912)
10. Vaidya VA, Siuciak JA, Du F, Duman RS (1999) Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience 89: 157-166. (Pubitemid 29049035)
11. Lamont SR, Paulls A, Stewart CA (2001) Repeated electroconvulsive stimulation, but not antidepressant drugs, induces mossy fibre sprouting in the rat hippocampus. Brain Res 893: 53-58. (Pubitemid 32171896)
12. Schwab ME (2010) Functions of Nogo proteins and their receptors in the nervous system. Nat Rev Neurosci 11: 799-811. doi:10.1038/nrn2936
13. Josephson A, Trifunovski A, Schéele C, Widenfalk J, Wahlestedt C, et al. (2003) Activity-induced and developmental downregulation of the Nogo receptor. Cell Tissue Res 311: 333-342. doi:10.1007/s00441-002-0695-8 (Pubitemid 36459672)
14. Endo T, Spenger C, Tominaga T, Brené S, Olson L (2007) Cortical sensory map rearrangement after spinal cord injury: fMRI responses linked to Nogo signalling. Brain 130: 2951-2961. doi:10.1093/brain/awm237 (Pubitemid 350033974)
15. Karlsson TE, Koczy J, Brené S, Olson L, Josephson A (2013) Differential Conserted Activity Induced Regulation of Nogo Receptors (1-3), LOTUS and Nogo mRNA in Mouse Brain. PLoS ONE 8: e60892. doi:10.1371/journal.- pone.0060892
16. McGee AW, Yang Y, Fischer QS, Daw NW, Strittmatter SM (2005) Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor. Science 309: 2222-2226. doi:10.1126/science.1114362 (Pubitemid 41396073)
17. Karlén A, Karlsson TE, Mattsson A, Lundströmer K, Codeluppi S, et al. (2009) Nogo receptor 1 regulates formation of lasting memories. Proc Natl Acad Sci USA 106: 20476-20481. doi:10.1073/pnas.0905390106
18. Wills ZP, Mandel-Brehm C, Mardinly AR, McCord AE, Giger RJ, et al. (2012) The nogo receptor family restricts synapse number in the developing hippocampus. Neuron 73: 466-481. doi:10.1016/j.neuron.2011.11.029
19. Sato Y, Iketani M, Kurihara Y, Yamaguchi M, Yamashita N, et al. (2011) Cartilage acidic protein-1B (LOTUS), an endogenous Nogo receptor antagonist for axon tract formation. Science 333: 769-773. doi:10.1126/science.1204144
20. Budel S, Padukkavidana T, Liu BP, Feng Z, Hu F, et al. (2008) Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci 28: 13161-13172. doi:10.1523/JNEUROSCI.3828-08.2008
21. Hsu R, Woodroffe A, Lai W-S, Cook MN, Mukai J, et al. (2007) Nogo Receptor 1 (RTN4R) as a candidate gene for schizophrenia: analysis using human and mouse genetic approaches. PLoS ONE 2: e1234. doi:10.1371/journal.-pone. 0001234
22. Novak G, Tallerico T (2006) Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA/TATC polymorphism in 3 9 - UTR. Brain Res 1120: 161-171. doi:10.1016/j.brainres.2006.08.071 (Pubitemid 44649294)
23. Sinibaldi L, De Luca A, Bellacchio E, Conti E, Pasini A, et al. (2004) Mutations of the Nogo-66 receptor (RTN4R) gene in schizophrenia. Hum Mutat 24: 534-535. doi:10.1002/humu.9292
24. Willi R, Weinmann O, Winter C, Klein J, Sohr R, et al. (2010) Constitutive genetic deletion of the growth regulator Nogo-A induces schizophrenia-related endophenotypes. J Neurosci 30: 556-567. doi:10.1523/JNEUROSCI.4393-09.2010
25. Karlsson TE, Karlén A, Olson L, Josephson A (2013) Neuronal overexpression of Nogo receptor 1 in APPswe/PSEN1(ΔE9) mice impairs spatial cognition tasks without influencing plaque formation. J Alzheimers Dis 33: 145-155. doi:10.3233/JAD-2012-120493
26. Park JH, Gimbel DA, GrandPre T, Lee J-K, Kim J-E, et al. (2006) Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition. J Neurosci 26: 1386-1395. doi:10.1523/JNEUROSCI.3291-05.2006 (Pubitemid 43237009)
27. Park JH,Widi GA, Gimbel DA, Harel NY, Lee DHS, et al. (2006) Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer's transgenic mice. J Neurosci 26: 13279-13286. doi:10.1523/JNEUROSCI. 4504-06.2006 (Pubitemid 46011638)
28. Zhu H-Y, Guo H-F, Hou H-L, Liu Y-J, Sheng S-L, et al. (2007) Increased expression of the Nogo receptor in the hippocampus and its relation to the neuropathology in Alzheimer's disease. Hum Pathol 38: 426-434. doi:10.1016/j.humpath.2006.09.010 (Pubitemid 46227533)
29. Zhou X, Hu X, HeW, Tang X, Shi Q, et al. (2011) Interaction between amyloid precursor protein and Nogo receptors regulates amyloid deposition. FASEB J 25: 3146-3156. doi:10.1096/fj.11-184325
30. Nations KR, Dogterom P, Bursi R, Schipper J, Greenwald S, et al. (2012) Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial. J Psychopharmacol (Oxford). doi:10.1177/0269881112458728
31. Garcia LSB, Comim CM, Valvassori SS, Réus GZ, Barbosa LM, et al. (2008) Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 32: 140-144. doi:10.1016/j.pnpbp.2007.07. 027
32. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, et al. (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47: 351-354. (Pubitemid 30109248)
33. Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17: 2921-2927. (Pubitemid 27155025)
34. Bai F, Bergeron M, Nelson DL (2003) Chronic AMPA receptor potentiator (LY451646) treatment increases cell proliferation in adult rat hippocampus. Neuropharmacology 44: 1013-1021. (Pubitemid 36570425)
35. Su XW, Li X-Y, Banasr M, Koo JW, Shahid M, et al. (2009) Chronic treatment with AMPA receptor potentiator Org 26576 increases neuronal cell proliferation and survival in adult rodent hippocampus. Psychopharmacology (Berl) 206: 215-222. doi:10.1007/s00213-009-1598-0
36. Hollmann M, Heinemann S (1994) Cloned glutamate receptors. Annu Rev Neurosci 17: 31-108. doi:10.1146/annurev.ne.17.030194.000335 (Pubitemid 24117025)
37. Wenthold RJ, Petralia RS, Blahos J II, Niedzielski AS (1996) Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J Neurosci 16: 1982-1989. (Pubitemid 26144011)
38. Bowie D, Mayer ML (1995) Inward rectification of both AMPA and kainate subtype glutamate receptors generated by polyamine-mediated ion channel block. Neuron 15: 453-462.
39. Pollard H, Héron A, Moreau J, Ben-Ari Y, Khrestchatisky M (1993) Alterations of the GluR-B AMPA receptor subunit flip/flop expression in kainate-induced epilepsy and ischemia. Neuroscience 57: 545-554. (Pubitemid 23350545)
40. Pellegrini-Giampietro DE, Zukin RS, Bennett MV, Cho S, Pulsinelli WA (1992) Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc Natl Acad Sci USA 89: 10499-10503.
41. Sommer B, Keinänen K, Verdoorn TA, Wisden W, Burnashev N, et al. (1990) Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 249: 1580-1585.
42. Dagerlind A, Friberg K, Bean AJ, Hökfelt T (1992) Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry 98: 39-49.
43. Josephson A, Widenfalk J, Widmer HW, Olson L, Spenger C (2001) NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury. Exp Neurol 169: 319-328. doi:10.1006/exnr.2001.7659 (Pubitemid 32524426)
44. Paxinos G, Ashwell KS, Törk I (1994) Atlas of the developing rat nervous system. Academic, San Diego, CA.
45. Altman J, Bayer SA (1997) The development of the cerebellar system. CRC Press, Boca Raton.
46. Paxinos G, Watson C (1998) The rat brain. Academic, San Diego, CA.
47. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675.
48. Dickendesher TL, Baldwin KT, Mironova YA, Koriyama Y, Raiker SJ, et al. (2012) NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. Nat Neurosci 15: 703-712. doi:10.1038/nn.3070
49. Cavalheiro EA, Riche DA, Le Gal La Salle G (1982) Long-term effects of intrahippocampal kainic acid injection in rats: a method for inducing spontaneous recurrent seizures. Electroencephalogr Clin Neurophysiol 53: 581-589.
50. Li S, Liu BP, Budel S, Li M, Ji B, et al. (2004) Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci 24: 10511-10520. doi:10.1523/JNEUROSCI.2828-04.2004 (Pubitemid 39552636)
51. Stewart C, Jeffery K, Reid I (1994) LTP-like synaptic efficacy changes following electroconvulsive stimulation. Neuroreport 5: 1041-1044. (Pubitemid 24160508)
52. Delekate A, Zagrebelsky M, Kramer S, Schwab ME, Korte M (2011) NogoA restricts synaptic plasticity in the adult hippocampus on a fast time scale. Proc Natl Acad Sci USA 108: 2569-2574. doi:10.1073/pnas.1013322108
53. Lee H, Raiker SJ, Venkatesh K, Geary R, Robak LA, et al. (2008) Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength. J Neurosci 28: 2753-2765. doi:10.1523/JNEUROSCI.5586-07.2008 (Pubitemid 351398865)
54. Buffo A, Zagrebelsky M, Huber AB, Skerra A, Schwab ME, et al. (2000) Application of neutralizing antibodies against NI-35/250 myelin-associated neurite growth inhibitory proteins to the adult rat cerebellum induces sprouting of uninjured purkinje cell axons. J Neurosci 20: 2275-2286. (Pubitemid 30230081)
55. Akbik FV, Bhagat SM, Patel PR, Cafferty WBJ, Strittmatter SM (2013) Anatomical plasticity of adult brain is titrated by Nogo Receptor 1. Neuron 77: 859-866. doi:10.1016/j.neuron.2012.12.027
56. Luo J, Min S, Wei K, Li P, Dong J, et al. (2011) Propofol protects against impairment of learning-memory and imbalance of hippocampal Glu/GABA induced by electroconvulsive shock in depressed rats. J Anesth 25: 657-665. doi:10.1007/s00540-011-1199-z
57. Andrade C, Shaikh SA, Narayan L, Blasey C, Belanoff J (2012) Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia. J Neural Transm 119: 337-344. doi:10.1007/s00702-011-0712-8
58. Andrade C, Thyagarajan S, Singh NM, Vinod PS, Sanjay Kumar Rao N, et al. (2008) Celecoxib as an in vivo probe of cyclooxygenase-2 mechanisms underlying retrograde amnesia in an animal model of ECT. J Neural Transm 115: 1063-1070. doi:10.1007/s00702-008-0063-2
59. Andrade C, Singh NM, Thyagarajan S, Nagaraja N, Sanjay Kumar Rao N, et al. (2008) Possible glutamatergic and lipid signalling mechanisms in ECT-induced retrograde amnesia: experimental evidence for involvement of COX-2, and review of literature. J Psychiatr Res 42: 837-850. doi:10.1016/j.jpsychires.2007.08.009
60. Hellsten J, West MJ, Arvidsson A, Ekstrand J, Jansson L, et al. (2005) Electroconvulsive seizures induce angiogenesis in adult rat hippocampus. Biol Psychiatry 58: 871-878. doi:10.1016/j.biopsych.2005.05.023 (Pubitemid 41790715)
61. Naylor P, Stewart CA, Wright SR, Pearson RC, Reid IC (1996) Repeated ECS induces GluR1 mRNA but not NMDAR1A-G mRNA in the rat hippocampus. Brain Res Mol Brain Res 35: 349-353. (Pubitemid 26036768)
62. Peng X, Kim J, Zhou Z, Fink DJ, Mata M (2011) Neuronal Nogo-A regulates glutamate receptor subunit expression in hippocampal neurons. J Neurochem 119: 1183-1193. doi:10.1111/j.1471-4159.2011.07520.x
63. Plant K, Pelkey KA, Bortolotto ZA, Morita D, Terashima A, et al. (2006) Transient incorporation of native GluR2-lacking AMPA receptors during hippocampal long-term potentiation. Nat Neurosci 9: 602-604. doi:10.1038/nn1678 (Pubitemid 44012255)
64. Noh K-M, Yokota H, Mashiko T, Castillo PE, Zukin RS, et al. (2005) Blockade of calcium-permeable AMPA receptors protects hippocampal neurons against global ischemia-induced death. Proc Natl Acad Sci USA 102: 12230-12235. doi:10.1073/pnas.0505408102 (Pubitemid 41291157)